Which chronic diseases contribute the most to healthy life years lost in Algeria?

Abstract

Objectives

Chronic diseases contribute significantly to healthy years lost (HYLs). It is critical to investigate which are the most contributing diseases to enable enhancing health programs’ effectiveness in improving health expectancy. This paper investigates disease-specific contributions to years lived with chronic diseases in Algeria and examines their recent evolution.

Methods

We used morbidity data from the last three waves of the Multiple Indicator Cluster Surveys of 2006, 2012–13, and 2018–19. The studied chronic diseases included hypertension, cardiovascular diseases (CVDs), joint diseases, respiratory diseases, and diabetes. We calculated disease-specific contributions using the cause-deleted health expectancy approach. Then, we analyzed time changes and gender-based differences in contributions.

Results

The leading cause of HYLs in women is hypertension, followed by diabetes, joint diseases, CVDs, and respiratory diseases. The same ranking applies to men, with joint diseases coming last. The time evolution of relative disease-specific contributions shows an increase in CVDs for women and diabetes for both genders, against a decrease for the other diseases.

Discussion

To improve chronic disease-free life expectancy in Algeria, effective prevention programs must be implemented, with an emphasis on hypertension and diabetes. Further investigation into the risk factors affecting the prevalence and incidence of these diseases is also required.

Keywords

Chronic diseases health expectancy contribution Algeria MICS

Get full access to this article

View all access options for this article.

References

Nusselder

Looman

. Decomposition of differences in health expectancy by cause. Demography 2004; 41: 315–334.

Gruenberg

. The failure of success. Milbank Mem Fund Q Health Soc 1977; 55: 3–24.

Nusselder

. Compression or expansion of morbidity: an exploration of the conditions. In: Compression or expansion of morbidity? A life-table approach. Rotterdam, The Netherlands: Erasmus University Rotterdam, 1998, pp.132–161.

Robine

Ritchie

. Healthy life expectancy: evaluation of global indicator of change in population health. Br Med J 1991; 302: 457–460.

Sanders

. Measuring community health levels. Am J Public Health Nations Health 1964; 54: 1063–1070.

Sullivan

. A single index of mortality and morbidity. HSMHA Health Rep 1971; 86: 347–354.

Saito

Robine

Crimmins

. The methods and materials of health expectancy. Stat J IAOS 2014; 30: 209–223.

World Health Organisation. Constitution of the world health organization. Geneva, Switzerland: The World Health Organization, 1948.

Mathers

Sadana

Salomon

, et al. Healthy life expectancy in 191 countries 1999. Lancet 2001; 357: 1685–1691.

10.

Kim

Jung

Ock

, et al. A review of the types and characteristics of healthy life expectancy and methodological issues. J Prev Med Public Health 2022; 55: 1–9.

11.

Chen

Wang

Crimmins

. The contributions of diseases to disability burden among the elderly population in China. J Aging Health 2014; 26: 261–282.

12.

Maximova

Rozen

Springett

, et al. The use of potential years of life lost for monitoring premature mortality from chronic diseases: Canadian perspectives. Can J Public Health 2016; 107: e202–e204.

13.

Chen

Zheng

, et al. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study. Br Med J 2019; 364: l969.

14.

Shiri

Hiilamo

Lallukka

. Indicators and determinants of the years of working life lost: a narrative review. Scand J Public Health 2021; 49: 666–674.

15.

Vos

Lim

Abbafati

, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204–1222.

16.

Flici

Chinoune

. Analysis of recent changes in chronic disease-free life expectancy in Algeria. East Mediterr Health J 2022; 28: 872–878.

17.

Chinoune

Flici

Saidi

. Analysis of the recent evolution of healthy life expectancy in the MENA region with a focus on Algeria. Tanzan J Health Res 2023; 24: 1–10.

18.

Bouhafs

. The reality of health indicators for the population of Algeria through the data of the National Multiple Indicator Cluster Survey 2019. J El-Bahith Hum Soc Sci 2021; 13: 555–566. https://www.asjp.cerist.dz/en/article/168054

19.

Lamri

Gripiotis

Ferrario

. Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications. Global Health 2014; 10: 11.

20.

Kouarah

Sali

. Chronic diseases in Algeria reality and perspectives. J El-Bahith Hum Soc Sci 2017; 9: 555–566. https://www.asjp.cerist.dz/en/downArticle/119/9/28/46607

21.

Robine

Jagger

and Euro-REVES Group. Creating a coherent set of indicators to monitor health across Europe: the Euro-REVES 2 project. Eur J Public Health 2003; 13(suppl_3): 6–14.

22.

Mathers

. Cause-deleted health expectancies. In: Robine

Jagger

Mathers

, et al. (eds) Determining health expectancies. England: John Wiley & Sons Editions, 2003, pp.149–174.

23.

Colvez

Blanchet

. Potential gains in life expectancy free of disability: a tool for health planning. Int J Epidemiol 1983; 12: 224–229.

24.

Mathers

. Gains in health expectancy from the elimination of diseases among older people. Disabil Rehabil 1999; 21: 211–221.

25.

Jagger

Van Oyen

Robine

. Health expectancy calculation by the Sullivan method: a practical guide. 4th ed. Newcastle, UK: Newcastle University, Institute of Ageing, 2014. https://reves.site.ined.fr/fichier/s_rubrique/20182/sullivan.guide.pre.final.oct2014.en.pdf.

26.

Bélanger

Martel

Berthelot

, et al. Gender differences in disability-free life expectancy for selected risk factors and chronic conditions in Canada. J Women Aging 2002; 14: 61–83.

27.

Laditka

. Effects of diabetes on healthy life expectancy: shorter lives with more disability for both women and men. In: Yi

Crimmins

Carrière

Robine

(eds) Longer life and healthy aging. International studies in population. Vol. 2. Dordrecht: Springer, 2006, pp.71–90. https://doi.org/10.1007/1-4020-4032-6_6 .

28.

Huerta

Tormo

Egea-Caparros

, et al. Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish population. DINO study findings. Rev Esp Cardiol 2009; 62: 143–152.

29.

Najafi

Moradinazar

Hamzeh

, et al. The reliability of self-reporting chronic diseases: how reliable is the result of population-based cohort studies. J Prev Med Hyg 2019; 60: E349–E353.

30.

Schoufour

Wang

, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. Br Med J 2020; 368: l6669.